Literature DB >> 17164952

Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.

Chao-Jen Lin1, Po-Yen Chen, Fang-Liang Huang, Tain Lee, Ching-Shiang Chi, Ching-Yuang Lin.   

Abstract

BACKGROUND AND
PURPOSE: The incidence of community-acquired lobar pneumonia in conjunction with either necrosis or empyema in children has rapidly increased in recent years. This study aimed to evaluate the radiographic, clinical, and predicted factors of complicated and uncomplicated lobar pneumonia in children.
METHODS: This retrospective study included 131 patients younger than 18 years of age with community-acquired lobar pneumonia treated between January 2002 and March 2005. Multiple logistic regression analysis was performed to demonstrate the risk factors of complicated lobar pneumonia.
RESULTS: The proportion of children with lobar pneumonia in children increased dramatically from 7% in 2002 to 19% in 2004. Analysis revealed the presence of elevated C-reactive protein level (>12 mg/dL) [odds ratio (OR), 3.51; 95% confidence interval (CI), 1.61-7.66], persistent fever for more than 1 week before admission (OR, 1.14; 95% CI, 1.04-1.26), and multilobar (> or =2 lobes) confluent lung opacity on chest radiographs (OR, 2.83; 95% CI, 1.27-6.33) were independent predictors of the occurrence of complicated lobar pneumonia. A progressive increase in the number of penicillin-non-susceptible Streptococcus pneumoniae isolates was found during the study period. Prolonged fever was a common clinical feature of hospitalized children with lobar pneumonia. Failure of consolidative pneumonia to respond to appropriate antibiotic treatment within 4.4 days was associated with the development of necrosis or empyema.
CONCLUSIONS: Complicated and uncomplicated lobar pneumonia are difficult to distinguish based on clinical symptoms at the time of admission. The presence of the above risk factors can help in the early diagnosis of complicated lobar pneumonia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17164952

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil.

Authors:  Juliana Caierão; Paulina Hawkins; Fernando Hayashi Sant'anna; Gabriela Rosa da Cunha; Pedro Alves d'Azevedo; Lesley McGee; Cícero Dias
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

2.  Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Authors:  Jeffrey M Bender; Krow Ampofo; Kent Korgenski; Judy Daly; Andrew T Pavia; Edward O Mason; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

Review 3.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

4.  The role of transthoracic ultrasonography in predicting the outcome of community-acquired pneumonia in hospitalized children.

Authors:  I-Chen Chen; Ming-Yen Lin; Yi-Ching Liu; Hsiao-Chi Cheng; Jiunn-Ren Wu; Jong-Hau Hsu; Zen-Kong Dai
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

5.  Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections.

Authors:  Verena Gotta; Philipp Baumann; Nicole Ritz; Aline Fuchs; Gurli Baer; Jessica M Bonhoeffer; Ulrich Heininger; Gabor Szinnai; Jan Bonhoeffer
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

6.  Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital.

Authors:  Anne Rowan-Legg; Nicholas Barrowman; Nazih Shenouda; Khaldoun Koujok; Nicole Le Saux
Journal:  BMC Pediatr       Date:  2012-08-28       Impact factor: 2.125

7.  Parapneumonic empyema deaths during past century, Utah.

Authors:  Jeffrey M Bender; Krow Ampofo; Xiaoming Sheng; Andrew T Pavia; Lisa Cannon-Albright; Carrie L Byington
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

8.  Discovery and validation of biomarkers to guide clinical management of pneumonia in African children.

Authors:  Honglei Huang; Readon C Ideh; Evelyn Gitau; Marie L Thézénas; Muminatou Jallow; Bernard Ebruke; Osaretin Chimah; Claire Oluwalana; Henri Karanja; Grant Mackenzie; Richard A Adegbola; Dominic Kwiatkowski; Benedikt M Kessler; James A Berkley; Stephen R C Howie; Climent Casals-Pascual
Journal:  Clin Infect Dis       Date:  2014-04-02       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.